BIOEKSEN
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

BIOEKSEN Trademark

Serial Number: 79360248 • Registration: 7296255

BIOEKSEN is a trademark filed by BIOEKSEN AR GE TEKNOLOJILERI ANONIM SIRKETI on August 19, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BIOEKSEN AR GE TEKNOLOJILERI ANONIM SIRKETI (2 trademarks)

Huzur Mahallesi, Metin Oktay Caddesi,

Entity Type: 99

Trademark Details

Filing Date

August 19, 2022

Registration Date

February 6, 2024

Published for Opposition

November 21, 2023

Goods & Services

Laboratory robots; test tubes for laboratory use; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; in vitro diagnostic testing apparatus, other than for medical use, namely, nucleic Acid Extraction robots, real time PCR instruments

Pharmaceutical preparations for the central nervous system; chemical preparations for sanitary purposes; in vitro gender prediction test kit; diagnostic kits comprising diagnostic agents, preparations and substances being reagents for medical purposes, namely, for diagnostic testing

Nucleic acid sequences, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis; reagents for scientific purposes for use in nucleic acid isolation and purification; biological preparations for use in industry and science; chemicals for use in biotechnological manufacturing processes; buffer solutions for scientific purposes

Medical examination services; medical assistance; medical testing for diagnostic or treatment purposes

Medical diagnostic testing apparatus for testing DNA and RNA samples, for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing, cancer cells caused by microbiological agents; medical diagnostic apparatus for testing for viruses; apparatus being diagnostic devices for viral agents for DNA and RNA testing for medical purposes

Computer software design; research and development in the field of biotechnology; biochemical engineering services; biotechnology research; research and development of new products for others; consulting services in the field of biotechnology

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jan 3, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 1, 2024 FINO
GENERIC MADRID TRANSACTION SENT TO IB
May 14, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
May 13, 2024 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 6, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 6, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 6, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Nov 27, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 21, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 6, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 1, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 1, 2023 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 17, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2023 CNSA
REFUSAL PROCESSED BY IB
Sep 26, 2023 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 31, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 24, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 24, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 24, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 22, 2023 TROA
REFUSAL PROCESSED BY IB
Aug 7, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 14, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jul 13, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 8, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jun 7, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 7, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 28, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 24, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 13, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 12, 2023 REPR